These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8839654)

  • 1. Auditing GPs' prescribing habits: cardiovascular prescribing frequently continues medication initiated by specialists.
    de Vries CS; van Diepen NM; Tromp TF; de Jong-van den Berg LT
    Eur J Clin Pharmacol; 1996; 50(5):349-52. PubMed ID: 8839654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey.
    Watkins C; Harvey I; Carthy P; Moore L; Robinson E; Brawn R
    Qual Saf Health Care; 2003 Feb; 12(1):29-34. PubMed ID: 12571342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General practitioners' prescriptions of benzodiazepines, Z-hypnotics and opioid analgesics for elderly patients during direct and indirect contacts. A cross-sectional, observational study.
    Sundseth AC; Gjelstad S; Straand J; Rosvold EO
    Scand J Prim Health Care; 2018 Jun; 36(2):115-122. PubMed ID: 29656692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is new drug prescribing in primary care specialist induced?
    Florentinus SR; Heerdink ER; van Dijk L; Griens AM; Groenewegen PP; Leufkens HG
    BMC Health Serv Res; 2009 Jan; 9():6. PubMed ID: 19134223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes and behaviour towards psychotropic drug prescribing in Swedish primary care: a questionnaire study.
    Svensson SA; Hedenrud TM; Wallerstedt SM
    BMC Fam Pract; 2019 Jan; 20(1):4. PubMed ID: 30611211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.
    Prosser H; Walley T
    Soc Sci Med; 2005 Mar; 60(6):1335-46. PubMed ID: 15626528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of the range of drugs prescribed in general practice: a cross-sectional analysis.
    de Bakker DH; Coffie DS; Heerdink ER; van Dijk L; Groenewegen PP
    BMC Health Serv Res; 2007 Aug; 7():132. PubMed ID: 17711593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing indicators. Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitioners.
    Muijrers PE; Janknegt R; Sijbrandij J; Grol RP; Knottnerus JA
    Eur J Clin Pharmacol; 2004 Dec; 60(10):739-46. PubMed ID: 15517226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telephone prescribing of antibiotics. General practitioners' views and reflections.
    Björnsdóttir I; Hansen EH
    Eur J Public Health; 2001 Sep; 11(3):260-3. PubMed ID: 11582603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General practitioners choose within a narrow range of drugs when initiating new treatments: a cohort study of cardiovascular drug formularies.
    Buusman A; Kragstrup J; Andersen M
    Eur J Clin Pharmacol; 2005 Oct; 61(9):651-6. PubMed ID: 16187132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug prescribing during direct and indirect contacts with patients in general practice. A report from the Møre & Romsdal Prescription Study.
    Rokstad K; Straand J
    Scand J Prim Health Care; 1997 Jun; 15(2):103-8. PubMed ID: 9232712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of specialists on prescribing by general practitioners.
    Robertson J; Fryer JL; O'Connell DL; Sprogis A; Henry DA
    Med J Aust; 2001 Oct; 175(8):407-11. PubMed ID: 11700832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?
    van Peet PG; Gussekloo J; den Elzen WP; Blom JW; de Waal MW; de Ruijter W
    Scand J Prim Health Care; 2015; 33(4):260-8. PubMed ID: 26683286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pharmacotherapy audit meetings on early new drug prescribing by general practitioners.
    Florentinus SR; van Hulten R; Kloth ME; Heerdink ER; Griens AM; Leufkens HG; Groenewegen PP;
    Ann Pharmacother; 2007 Feb; 41(2):319-24. PubMed ID: 17244644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dutch GPs' perceptions: the influence of out-of-pocket costs on prescribing.
    Kasje WN; Timmer JW; Boendermaker PM; Haaijer-Ruskamp FM
    Soc Sci Med; 2002 Nov; 55(9):1571-8. PubMed ID: 12297243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prescribing of specialist medicines: what factors influence GPs' decision making?
    Crowe S; Tully MP; Cantrill JA
    Fam Pract; 2009 Aug; 26(4):301-8. PubMed ID: 19505976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing GPs' choice between drugs in a therapeutic drug group. A qualitative study.
    Buusman A; Andersen M; Merrild C; Elverdam B
    Scand J Prim Health Care; 2007 Dec; 25(4):208-13. PubMed ID: 18041657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary care physicians' adoption of new drugs is not associated with their clinical interests: a pharmacoepidemiologic study.
    Dybdahl T; Søndergaard J; Kragstrup J; Kristiansen IS; Andersen M
    Scand J Prim Health Care; 2011 Jun; 29(2):117-21. PubMed ID: 21510719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General practitioners' perceptions of antimicrobial resistance: a qualitative study.
    Simpson SA; Wood F; Butler CC
    J Antimicrob Chemother; 2007 Feb; 59(2):292-6. PubMed ID: 17110392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General practitioners for rational use of drugs. Examples from Sweden.
    Tomson Y; Wessling A; Tomson G
    Eur J Clin Pharmacol; 1994; 47(3):213-9. PubMed ID: 7867673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.